HeartSciences Net Long-Term Debt 2022-2025 | HSCS

HeartSciences net long-term debt from 2022 to 2025. Net long-term debt can be defined as the net amount of long term debt issued and repaid. This field is either calculated as the sum of the long term debt fields or used if a company does not report debt issued and repaid separately
HeartSciences Annual Net Long-Term Debt
(Millions of US $)
2024 $0
2023 $0
2022 $1
2021 $1
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.004B $0.000B
Heart Test Laboratories, Inc. d/b/a HeartSciences is a medical technology company focused on applying innovative AI-based technology to an ECG (also known as an EKG) to expand and improve an ECG's clinical utility. Millions of ECGs are performed every week and the Company's objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. HeartSciences has one of the largest libraries of AI-ECG algorithms and is developing AI-ECG solutions to be made available on either a hardware agnostic cloud-based platform or its proprietary MyoVista? wavECG(TM) device, to help identify cardiovascular disease in any care setting worldwide in a manner to best suit different care providers. HeartSciences' first product candidate for FDA clearance, the MyoVista? wavECG(TM), or the MyoVista(R), is a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.427B 59.33
Hims & Hers Health (HIMS) United States $12.608B 131.00
Tempus AI (TEM) United States $10.745B 0.00
IRhythm Technologies (IRTC) United States $4.683B 0.00
Inspire Medical Systems (INSP) United States $4.012B 62.68
Hinge Health (HNGE) United States $3.034B 0.00
Privia Health (PRVA) United States $2.827B 193.25
Enovis (ENOV) United States $1.816B 10.12
Schrodinger (SDGR) United States $1.807B 0.00
Phreesia (PHR) United States $1.595B 0.00
Clover Health Investments (CLOV) United States $1.555B 0.00
Omnicell (OMCL) United States $1.452B 25.62
Azenta (AZTA) United States $1.316B 61.17
10x Genomics (TXG) United States $1.160B 0.00
Fulgent Genetics (FLGT) United States $0.652B 0.00
Claritev (CTEV) United States $0.650B 0.00
Butterfly Network (BFLY) United States $0.613B 0.00
Talkspace (TALK) United States $0.550B 164.50
Veradigm (MDRX) United States $0.476B 0.00
Standard BioTools (LAB) United States $0.403B 0.00
Outset Medical (OM) United States $0.371B 0.00
TruBridge (TBRG) United States $0.358B 794.00
Health Catalyst (HCAT) United States $0.285B 0.00
Nyxoah SA (NYXH) Belgium $0.261B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.209B 0.00
KORU Medical Systems (KRMD) United States $0.142B 0.00
EUDA Health Holdings (EUDA) Singapore $0.128B 0.00
Pulmonx (LUNG) United States $0.128B 0.00
American Well (AMWL) United States $0.109B 0.00
MDxHealth SA (MDXH) Belgium $0.098B 0.00
CareCloud (CCLD) United States $0.092B 3.52
111 (YI) China $0.073B 0.00
HeartBeam (BEAT) United States $0.056B 0.00
P3 Health Partners (PIII) United States $0.048B 0.00
Zepp Health (ZEPP) Netherlands $0.034B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.031B 0.00
Zhongchao (ZCMD) China $0.027B 0.00
Streamline Health Solutions (STRM) United States $0.022B 0.00
Precipio (PRPO) United States $0.017B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Movano (MOVE) United States $0.005B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00